- Home
- SGMT vs MFIN Comparison
SGMT vs MFIN Comparison
Compare SGMT & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- MFIN
- Stock Information
- Founded
- SGMT 2006
- MFIN 1995
- Country
- SGMT United States
- MFIN United States
- Employees
- SGMT N/A
- MFIN N/A
- Industry
- SGMT
- MFIN Finance: Consumer Services
- Sector
- SGMT
- MFIN Finance
- Exchange
- SGMT Nasdaq
- MFIN Nasdaq
- Market Cap
- SGMT 230.3M
- MFIN 223.8M
- IPO Year
- SGMT 2023
- MFIN 1996
- Fundamental
- Price
- SGMT $7.11
- MFIN $10.71
- Analyst Decision
- SGMT Strong Buy
- MFIN Strong Buy
- Analyst Count
- SGMT 7
- MFIN 1
- Target Price
- SGMT $26.57
- MFIN $12.00
- AVG Volume (30 Days)
- SGMT 601.4K
- MFIN 42.9K
- Earning Date
- SGMT 08-13-2025
- MFIN 10-28-2025
- Dividend Yield
- SGMT N/A
- MFIN 4.48%
- EPS Growth
- SGMT N/A
- MFIN N/A
- EPS
- SGMT N/A
- MFIN 1.75
- Revenue
- SGMT N/A
- MFIN $332,256,000.00
- Revenue This Year
- SGMT N/A
- MFIN N/A
- Revenue Next Year
- SGMT N/A
- MFIN $1.53
- P/E Ratio
- SGMT N/A
- MFIN $6.12
- Revenue Growth
- SGMT N/A
- MFIN 16.48
- 52 Week Low
- SGMT $1.73
- MFIN $7.40
- 52 Week High
- SGMT $11.41
- MFIN $10.98
- Technical
- Relative Strength Index (RSI)
- SGMT 39.46
- MFIN 60.53
- Support Level
- SGMT $7.01
- MFIN $10.27
- Resistance Level
- SGMT $7.68
- MFIN $10.73
- Average True Range (ATR)
- SGMT 0.51
- MFIN 0.27
- MACD
- SGMT -0.02
- MFIN 0.00
- Stochastic Oscillator
- SGMT 39.03
- MFIN 80.95
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.